Filamin B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-88143
Key Product Details
Validated by
Biological Validation
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation (Negative), Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.2 mg/ml
Product Summary for Filamin B Antibody
Immunogen
The immunogen recognized by this antibody maps to a region between residue 1225 and 1275 of human filamin B, beta (actin binding protein 278) using the numbering given in entry NP_001448.2 (GeneID 2317).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Filamin B Antibody
Applications for Filamin B Antibody
Application
Recommended Usage
Western Blot
1:2000-1:10000
Application Notes
This antibody is useful for western blot. It is not recommended for immunoprecipitation.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
TBS and 0.1% BSA
Preservative
0.09% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: Filamin B
Alternate Names
ABP-278filamin B, beta (actin binding protein 278), ABP-280 homolog, actin binding protein 278, Actin-binding-like protein, AOI, beta-filamin, DKFZp686O033, Fh1, filamin B, beta, Filamin homolog 1, Filamin-3, filamin-B, FLN1L, FLN3, FLN-B, Larsen syndrome 1 (autosomal dominant), LRS1, SCT, TABPABP-280, TAPDKFZp686A1668, Thyroid autoantigen, Truncated ABP, Truncated actin-binding protein
Entrez Gene IDs
2317 (Human)
Gene Symbol
FLNB
UniProt
Additional Filamin B Products
Product Documents for Filamin B Antibody
Product Specific Notices for Filamin B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...